FACS analysis of Daudi cells using GTX01487-08 CD80 antibody [2D10.4] (PE). Solid lone : primary antibody Dashed line : isotype control antibody amount : 0.5 microg (5 microl)
CD80 antibody [2D10.4] (PE)
GTX01487-08
ApplicationsFlow Cytometry
Product group Antibodies
ReactivityHuman, Primate
TargetCD80
Overview
- SupplierGeneTex
- Product NameCD80 antibody [2D10.4] (PE)
- Delivery Days Customer9
- Application Supplier NoteFACS: 0.5 microg (5 microl) for 105-108 cells in 100 microl sample per test. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
- ApplicationsFlow Cytometry
- CertificationResearch Use Only
- ClonalityMonoclonal
- Clone ID2D10.4
- Concentration0.1 mg/ml
- ConjugateRPE
- FormulationLiquid
- Gene ID941
- Target nameCD80
- Target descriptionCD80 molecule
- Target synonymsactivation B7-1 antigen; B7; B7.1; B7-1; BB1; B-lymphocyte activation antigen B7; CD28LG; CD28LG1; CD80 antigen (CD28 antigen ligand 1, B7-1 antigen); costimulatory factor CD80; costimulatory molecule variant IgV-CD80; CTLA-4 counter-receptor B7.1; LAB7; T-lymphocyte activation antigen CD80
- HostMouse
- IsotypeIgG1
- Protein IDP33681
- Protein NameT-lymphocyte activation antigen CD80
- Scientific DescriptionThe protein encoded by this gene is a membrane receptor that is activated by the binding of CD28 or CTLA-4. The activated protein induces T-cell proliferation and cytokine production. This protein can act as a receptor for adenovirus subgroup B and may play a role in lupus neuropathy. [provided by RefSeq, Aug 2011]
- ReactivityHuman, Primate
- Storage Instruction2°C to 8°C
- UNSPSC12352203
References
- Contact-dependent carcinoma aggregate dispersion by M2a macrophages via ICAM-1 and beta2 integrin interactions. Bai J et al., 2015 Sep 22, OncotargetRead more
- Genuine Immunomodulation With dSLIM. Kapp K et al., 2014 Jun 24, Mol Ther Nucleic AcidsRead more
- Renal allograft rejection is prevented by adoptive transfer of anergic T cells in nonhuman primates. Bashuda H et al., 2005 Jul, J Clin InvestRead more